Medtronic Showcases Neuromodulation Advances and Long-Term Data at NANS Annual Meeting

Reuters01-20 22:36
Medtronic Showcases Neuromodulation Advances and Long-Term Data at NANS Annual Meeting

Medtronic plc will participate in the North American Neuromodulation Society (NANS) 2026 Annual Meeting from January 22-25, 2026, at Caesars Palace in Las Vegas. The company will present new long-term clinical data for its Inceptiv™ spinal cord stimulation system and highlight advances in sensing-enabled neuromodulation therapies. Featured activities include oral abstract presentations, a multidisciplinary lunch symposium on the future of neuromodulation, and hands-on demonstrations of Medtronic technologies for early-career physicians.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief on January 20, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment